HIM
AMED

Hillsdale Investment Management’s Amedisys AMED Stock Holding History

Hillsdale Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,785
Closed -$473K – 566
2021
Q1 		$473K Buy
1,785
+1,750
+5,000% +$494K 0.04% 373
2020
Q4 		$10K Buy
+35
New +$8.97K ﹤0.01% 493
2020
Q3 		– Sell
-4,400
Closed -$874K – 573
2020
Q2 		$874K Buy
4,400
+600
+16% +$112K 0.08% 194
2020
Q1 		$697K Sell
3,800
-2,000
-34% -$356K 0.08% 213
2019
Q4 		$968K Buy
+5,800
New +$863K 0.08% 200

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Hillsdale Investment Management's AMED Position: Q2 2021 in Review

Hillsdale Investment Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,785 shares — an estimated $473K sold.

Hillsdale Investment Management first reported a position in AMED in Q4 2019 and held it in 5 quarters. The position peaked at $968K in Q4 2019. 376 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Hillsdale Investment Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,785 Amedisys shares in Q2 2021, an estimated $473K.
  • Hillsdale Investment Management first reported a position in Amedisys in Q4 2019 and held it in 5 quarters.
  • Hillsdale Investment Management's Amedisys position peaked at $968K in Q4 2019.
  • 376 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Hillsdale Investment Management's 13F filing for Q2 2021, filed 29 Jul 2021.